Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 379

1.

Stockpiling antiviral drugs for the next influenza pandemic.

Patel A, Gorman SE.

Clin Pharmacol Ther. 2009 Sep;86(3):241-3. doi: 10.1038/clpt.2009.142.

PMID:
19707215
2.

Influenza a (H1N1) outbreak and challenges for pharmacotherapy.

Chawla R, Sharma RK, Bhardwaj JR.

Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):113-26. Review.

PMID:
20112815
3.

Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.

Lugnér AK, Postma MJ.

Eur J Public Health. 2009 Oct;19(5):516-20. doi: 10.1093/eurpub/ckp119. Epub 2009 Aug 19.

PMID:
19692550
4.

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

Ward P, Small I, Smith J, Suter P, Dutkowski R.

J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. Review.

PMID:
15709056
5.

Antiviral agents for influenza: molecular targets, concerns of resistance, and new treatment options.

Maltezou HC, Tsiodras S.

Curr Drug Targets. 2009 Oct;10(10):1041-8. Review.

PMID:
19860646
6.

[The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].

Uhnoo I, Bergquist C.

Lakartidningen. 2009 Jul 8-21;106(28-29):1814-9. Review. Swedish. No abstract available.

PMID:
19685621
7.

Influenza and the pandemic threat.

Lee VJ, Fernandez GG, Chen MI, Lye D, Leo YS.

Singapore Med J. 2006 Jun;47(6):463-70. Review.

8.

[Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].

Boibieux A.

Ann Fr Anesth Reanim. 2010 Feb;29(2):85-6. doi: 10.1016/j.annfar.2010.01.005. French. No abstract available.

PMID:
20167451
9.

Pandemic flu vaccine: are we doing enough?

Campbell JD.

Clin Pharmacol Ther. 2007 Dec;82(6):633-5.

PMID:
17998908
10.

HHS-CDC NEWS: update: influenza activity--US and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine.

[No authors listed]

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1499-500. Epub 2006 Jul 18. No abstract available.

PMID:
16849615
11.

Swine flu outbreak. What role for antiviral drugs?

Couzin-Frankel J.

Science. 2009 May 8;324(5928):705. doi: 10.1126/science.324_705. No abstract available.

PMID:
19423784
12.

Ethical guidelines in pandemic influenza: recommendations of the Ethics Subcommittee of the Advisory Committee of the Director, Centers for Disease Control and Prevention.

Kinlaw K, Barrett DH, Levine RJ.

Disaster Med Public Health Prep. 2009 Dec;3 Suppl 2:S185-92. doi: 10.1097/DMP.0b013e3181ac194f.

PMID:
19675459
13.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.

14.

[The use of anti-viral agents in pandemic influenza, Icelandic guidelines].

Gudnason T, Sigmundsdottir G, Briem H.

Laeknabladid. 2008 Jan;94(1):19-25. Review. Icelandic.

PMID:
18204108
15.

Influenza pandemic preparedness: can we handle the truth?

Kay M.

Am J Nurs. 2005 Dec;105(12):73-4. No abstract available.

PMID:
16327399
16.

An influenza prophylaxis clinic in a primary school: 24 hours from notification to protection.

Weston KM, Truman G.

N S W Public Health Bull. 2010 Jan-Feb;21(1-2):16-8. doi: 10.1071/NB09032.

18.

Influenza virus resistance to oseltamivir: what are the implications?

Fleming DM, Elliot AJ, Meijer A, Paget WJ.

Eur J Public Health. 2009 Jun;19(3):238-9. doi: 10.1093/eurpub/ckp012. Epub 2009 Feb 12. No abstract available.

PMID:
19221019
19.

Pandemic influenza: is there a corporate duty to prepare?

McMenamin JP.

Food Drug Law J. 2009;64(1):69-100.

PMID:
19998573
20.

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.

Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, Payungporn S, Poovorawan Y, Hannongbua S.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):390-4. doi: 10.1016/j.bbrc.2009.05.066. Epub 2009 May 20.

PMID:
19463784

Supplemental Content

Support Center